Dr. Kevin Song graduated from McGill University Medical School in 1995. He completed his hematology sub-specialization at the University of British Columbia followed by fellowships with the Leukemia Bone Marrow Transplant Program of British Columbia and the University of Toronto Autologous Blood and Marrow Transplant Program at Princess Margaret Hospital. He has been with the Program since 2002. His areas of interest are in the study of therapies for myeloma and lymphomas. He was previously Vice-Chair of the Board of the Canada Myeloma Research Group. He is also actively involved in CAR T-cell therapies acting as the local PI for studies as well as being involved in committees for the implementation of CAR T-cells as standard therapies.